Rather than giving antioxidant benefits, they may harm
Heavy or Dependent Drinking If alcohol consumption exceeds 14+ drinks per week, or if stopping creates withdrawal symptoms: Medical supervision is essential: Combining retatrutide with heavy alcohol use requires close monitoring Address alcohol use first: Consider addiction medicine consultation before optimizing weight loss medication GLP-1 agonists may reduce alcohol cravings: Emerging research suggests these medications decrease alcohol seeking behavior in some people Liver damage risk is significant: The combination creates substantial hepatotoxic potential Consider treatment programs: Resources like CAMH (Centre for Addiction and Mental Health) offer evidence-based approaches Interestingly, some research suggests GLP-1 receptor agonists may actually help reduce alcohol consumption in people with alcohol use disorder, though this remains an area of active investigation rather than established clinical practice

Ozempic mimics hormones that reduce appetite, slow the movement of food and moderate insulin release
Current research suggests that there are no significant interactions between GLP-1RAs and bisphosphonates
Anti-aging effects: NAD+ has been shown to support healthy aging by improving mitochondrial function, reducing inflammation, and supporting DNA repair
Overall, we found NADH-Phasor FLIM to be an effective, non-invasive method of monitoring changes in metabolism over a prolonged period of time